Skip to content
★ Sign in to follow
DS
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€118k
▼ Sales (0 ops.)
—

Latest filing published 06 Sept 2016 for Cocrystal Pharma, Inc., €3,660.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-8.7%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 06 Sept 2016 · 3716 days ago · €3,660
    -43.1%
    Entry US$183.60 · Close at T+365 US$104.40
  • Filed 17 Mar 2016 · 3889 days ago · €23k
    -59.3%
    Entry US$212.40 · Close at T+365 US$86.40
  • Filed 27 Mar 2015 · 4245 days ago · €92k
    -46.8%
    Entry US$453.60 · Close at T+365 US$241.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David S. Block: trading record in brief

All filings by David S. Block on record concern Cocrystal Pharma, Inc. Over a trading history stretching from 25 March 2015 to 1 September 2016, the count stands at 3 filings.

Purchases make up the whole of the open-market record (3 purchases, €118k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2016 alone, the filings show 2 purchases and no sales.

A typical purchase (the median) is worth €23k. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -8.7%. Past outcomes like these are no guarantee of what comes next.

On 6 September 2016 came the latest disclosure, an open-market purchase for €3,660 in Cocrystal Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David S. Block

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    DirectorExecutivesCocrystal Pharma, Inc.
    4,100 USD29SEC
    10,000 shares@ US$0.4113.7% of flowCommon StockSEC:0001415889-16-007052:0
    Canonical exit: 30 Nov 2016 (T+90)
  • ▲
    DirectorExecutivesCocrystal Pharma, Inc.
    25,500 USD37SEC
    50,000 shares@ US$0.5186.3% of flowCommon StockSEC:0001415889-16-005137:0
    Canonical exit: 13 Jun 2016 (T+90)
  • ▲
    DirectorExecutivesCocrystal Pharma, Inc.
    100,000 USD0SEC
    108,696 shares@ US$0.92Common StockSEC:0001415889-15-001071:0
    Canonical exit: 23 Jun 2015 (T+90)

3 of 3 declarations